HIV Funding Impacts Global health funding · LMIC Download the panel

Home  /  Eastern Europe and Central Asia  /  AZE

Azerbaijan

Azerbaijan appears only through international and donor bodies that compile figures across many countries, and no figures for the country are read directly from a national publisher. The assessment of national sources, country by country, is set out on the Methods page.

12,000
People living with HIV, 2025
WHO Global Health Observatory
81.0%
On antiretroviral treatment, 2025
WHO Global Health Observatory
$6k
United States HIV disbursements, 2024
OECD Creditor Reporting System
$4.2m
External HIV financing, all donors, 2024
OECD Creditor Reporting System
External HIV financing
OECD CRS · ForeignAssistance.gov
$0$5m$10m20022005200820112014201720202023$4.2m$6k$4.2m$30k
  • All donors
  • United States, OECD record
  • The Global Fund
  • United States, self-reported
YearAll donorsUnited States, OECD recordThe Global FundUnited States, self-reported
2002 $32k — — —
2003 $24k — — —
2004 $18k — — —
2005 $1.2m $78k $966k $78k
2006 $5.3m — $5.1m —
2007 $2.0m — $1.6m —
2008 $2.4m $20k $2.3m $20k
2009 $563k $80k $392k $80k
2010 $4.8m — $4.6m —
2011 $8.4m — $8.1m $0
2012 $2.1m — $1.8m —
2013 $5.3m — $5.0m —
2014 $6.9m — $6.8m —
2015 $2.4m — $2.4m —
2016 $3.1m — $3.1m —
2017 $2.6m — $2.6m —
2018 $2.6m — $2.6m —
2019 $2.1m — $2.1m —
2020 $3.0m — $3.0m —
2021 $7.2m — $7.2m —
2022 $9.6m — $9.6m —
2023 $4.5m $24k $4.5m —
2024 $4.2m $6k $4.2m $30k

23 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment
UNAIDS AIDSinfo
05k10k2000200320062009201220152018202120249,9008,500
  • People living with HIV
  • People on treatment
YearPeople living with HIVPeople living with HIV (lower)People living with HIV (upper)People on treatment
2000 3,900 2,600 5,400 —
2001 4,600 3,100 6,100 —
2002 5,100 3,700 6,900 —
2003 5,700 4,200 7,500 —
2004 6,100 4,700 8,000 —
2005 6,500 5,100 8,500 —
2006 6,800 5,300 8,600 —
2007 7,000 5,600 8,800 —
2008 7,300 5,800 9,000 —
2009 7,500 6,000 9,200 —
2010 7,700 6,200 9,300 500
2011 7,800 6,400 9,500 710
2012 8,000 6,500 9,700 910
2013 8,100 6,700 9,900 1,300
2014 8,300 6,900 10,000 1,800
2015 8,400 7,100 10,000 2,300
2016 8,500 7,300 10,000 2,800
2017 8,700 7,500 10,000 3,400
2018 8,900 7,700 10,000 4,100
2019 9,100 7,900 11,000 5,100
2020 9,300 8,100 11,000 5,600
2021 9,500 8,100 11,000 6,200
2022 9,600 8,200 11,000 6,400
2023 9,800 8,300 11,000 7,500
2024 9,900 8,400 12,000 8,500

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade
UNAIDS AIDSinfo
-50%0%50%100%2010201220142016201820202022202498.0%86.0%80.0%
  • Diagnosed
  • On treatment
  • Virally suppressed
YearDiagnosedOn treatmentVirally suppressed
2010 26.0% 6.0% —
2011 31.0% 9.0% —
2012 36.0% 11.0% —
2013 40.0% 15.0% —
2014 46.0% 21.0% —
2015 53.0% 27.0% —
2016 59.0% 33.0% —
2017 64.0% 39.0% 29.0%
2018 69.0% 46.0% 38.0%
2019 75.0% 56.0% 45.0%
2020 78.0% 60.0% 52.0%
2021 83.0% 66.0% 54.0%
2022 89.0% 67.0% 64.0%
2023 95.0% 76.0% 71.0%
2024 98.0% 86.0% 80.0%

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

Sources of the figures for Azerbaijan

2,757 rows

SourceTypeRowsIndicators YearsRead fromRetrieved
UNICEF HIV/AIDS dataset Modelled estimate 1,376 5 2010–2025 sdmx.data.unicef.org 2026-10-20
UNAIDS AIDSinfo Modelled estimate 624 27 2000–2024 aidsinfo.unaids.org 2026-10-20
WHO Global Health Observatory Modelled estimate 251 12 2000–2025 ghoapi.azureedge.net 2026-10-12
WHO Global Tuberculosis Programme Programme record 135 15 2000–2025 extranet.who.int 2026-10-16
Global Fund Data Service Programme record 91 8 2017–2025 fetch.theglobalfund.org 2026-10-12
World Bank Open Data Modelled estimate 51 2 2000–2025 api.worldbank.org 2026-10-12
OECD Creditor Reporting System Expenditure account 48 3 2002–2024 sdmx.oecd.org 2026-10-12
WHO Europe Health for All database Programme record 40 2 2000–2019 dw.euro.who.int 2026-10-21
IATI, through d-portal Expenditure account 32 3 2005–2026 d-portal.org 2026-10-12
UNAIDS Global AIDS Monitoring expenditure database Expenditure account 26 12 2021–2024 hivfinancial.unaids.org 2026-10-12
Demographic and Health Surveys Survey 23 2 2006 api.dhsprogram.com 2026-10-16
WHO HIV testing services dashboard Programme record 22 4 2018–2024 eic-database-290813.ew.r.appspot.com 2026-10-14
HIV/AIDS surveillance in Europe 2025, the joint report of ECDC (the European Centre for Disease Prevention and Control) and the WHO Regional Office for Europe, Tables 1 and 13 Programme record 20 2 2015–2024 ecdc.europa.eu 2026-10-21
ForeignAssistance.gov Expenditure account 10 2 2005–2024 foreignassistance.gov 2026-10-29
Global Fund allocations Expenditure account 4 1 2017–2026 fetch.theglobalfund.org 2026-10-12
UNAIDS Data 2025 country databook Expenditure account 4 2 2021–2023 aidsinfo.unaids.org 2026-10-15

Indicators held

69 of 150

IndicatorDomainUnitRows YearsSourcesMost recent value
Actual expenditure on collaborative TB/HIV activities Financing USD 4 2018–2024 WHO Global Tuberculosis Programme $222k (2024)
Budget required for collaborative TB/HIV activities Financing USD 4 2019–2025 WHO Global Tuberculosis Programme $267k (2025)
Country-reported HIV expenditure, all sources Financing USD 8 2013–2024 UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database $10.3m (2024)
Domestic funding received by the national TB programme Financing USD 6 2018–2024 WHO Global Tuberculosis Programme $22.7m (2024)
Domestic public HIV expenditure Financing USD 5 2021–2024 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $9.7m (2024)
Expected Global Fund funding for the national TB programme Financing USD 6 2019–2025 WHO Global Tuberculosis Programme $3.2m (2025)
Expected domestic funding for the national TB programme Financing USD 6 2019–2025 WHO Global Tuberculosis Programme $25.1m (2025)
Expected funding for collaborative TB/HIV activities Financing USD 4 2019–2025 WHO Global Tuberculosis Programme $267k (2025)
External HIV financing (all donors, ODA) Financing USD 23 2002–2024 OECD Creditor Reporting System $4.2m (2024)
External HIV financing from governments other than the United States (IATI) Financing USD 1 2009 IATI, through d-portal $13k (2009)
External HIV financing from multilateral bodies other than the Global Fund (IATI) Financing USD 9 2014–2026 IATI, through d-portal $4k (2026)
External HIV financing from the United States (ODA) Financing USD 10 2005–2024 ForeignAssistance.gov, OECD Creditor Reporting System $6k (2024)
Funding received for collaborative TB/HIV activities Financing USD 4 2018–2024 WHO Global Tuberculosis Programme $222k (2024)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure Financing USD per three-year allocation cycle 4 2017–2026 Global Fund allocations 7,814,350 (2026)
Global Fund HIV disbursements to the country Financing USD 45 2005–2026 IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database $3.4m (2026)
Global Fund funding received by the national TB programme Financing USD 6 2018–2024 WHO Global Tuberculosis Programme $2.2m (2024)
HIV spending on TB/HIV co-infection Financing USD 1 2024 UNAIDS Global AIDS Monitoring expenditure database $125k (2024)
HIV spending on community mobilisation and system strengthening Financing USD 1 2024 UNAIDS Global AIDS Monitoring expenditure database $40k (2024)
HIV spending on critical enablers Financing USD 2 2023–2024 UNAIDS Global AIDS Monitoring expenditure database $4k (2024)
HIV spending on governance and sustainability Financing USD 2 2023–2024 UNAIDS Global AIDS Monitoring expenditure database $2.7m (2024)
HIV spending on prevention Financing USD 2 2023–2024 UNAIDS Global AIDS Monitoring expenditure database $3.0m (2024)
HIV spending on prevention of vertical transmission Financing USD 1 2024 UNAIDS Global AIDS Monitoring expenditure database $189k (2024)
HIV spending on social protection and economic support Financing USD 2 2021–2024 UNAIDS Global AIDS Monitoring expenditure database $294k (2024)
HIV spending on treatment, care and support Financing USD 3 2021–2024 UNAIDS Global AIDS Monitoring expenditure database $3.9m (2024)
International HIV expenditure (country-reported) Financing USD 5 2021–2024 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $550k (2024)
US HIV disbursements managed by USAID Financing USD 5 2005–2024 ForeignAssistance.gov $30k (2024)
% of ALL PLHIV who are virally suppressed Treatment cascade percent 17 2017–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 76.0% (2025)
% of PLHIV on ART (second 95, PLHIV base) Treatment cascade percent 68 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 81.0% (2025)
% of PLHIV who have been diagnosed (first 95) Treatment cascade percent 28 2010–2024 UNAIDS AIDSinfo, WHO Global Health Observatory 98.0% (2024)
% of estimated HIV-positive incident TB cases on TB treatment and ART Treatment cascade percent 15 2003–2024 UNAIDS AIDSinfo 56.3% (2024)
% of people currently enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 4 2019–2024 UNAIDS AIDSinfo 20.5% (2024)
% of people living with HIV on ART who completed a course of TB preventive therapy Treatment cascade percent 3 2022–2024 UNAIDS AIDSinfo 60.9% (2024)
% of people newly enrolled in HIV treatment diagnosed with TB disease Treatment cascade percent 12 2013–2024 UNAIDS AIDSinfo 2.0% (2024)
% of people newly enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 10 2013–2024 UNAIDS AIDSinfo 96.4% (2024)
% of people on ART who are virally suppressed (third 95) Treatment cascade percent 9 2017–2025 WHO Global Health Observatory 94.0% (2025)
% of returned HIV test results that were positive Treatment cascade percent 18 2018–2024 UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 0.1% (2024)
HIV self-test kits distributed Treatment cascade count 2 2023–2024 WHO HIV testing services dashboard 12,614 (2024)
HIV tests performed at a health facility Treatment cascade count 4 2018–2024 WHO HIV testing services dashboard 824,576 (2024)
HIV tests performed with the result returned to the person Treatment cascade count 26 2017–2024 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 824,576 (2024)
HIV-exposed infants tested within two months of birth Treatment cascade percent 14 2010–2024 UNAIDS AIDSinfo 98.0% (2024)
HIV-positive TB patients started or continued on ART Treatment cascade count 17 2015–2024 Global Fund Data Service, WHO Global Tuberculosis Programme 43 (2024)
Key-population people tested for HIV (count over the period) Treatment cascade count 32 2017–2025 Global Fund Data Service By population group, sex or age only, to 2025
New HIV diagnoses with a CD4 count below 200 Treatment cascade percent 6 2015–2024 UNAIDS AIDSinfo 1.0% (2024)
Notified HIV cases, national case surveillance Treatment cascade count 30 2000–2024 HIV/AIDS surveillance in Europe 2025, the joint report of ECDC (the European Centre for Disease Prevention and Control) and the WHO Regional Office for Europe, Tables 1 and 13, WHO Europe Health for All database 1,171 (2024)
Number of people on ART (PEPFAR MER TX_CURR) Treatment cascade count 78 2000–2025 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO Global Tuberculosis Programme 9,749 (2025)
PMTCT ART coverage among pregnant women with HIV Treatment cascade percent 16 2010–2025 UNICEF HIV/AIDS dataset 79.0% (2025)
People newly enrolled on ART during the year Treatment cascade count 12 2013–2024 WHO Global Tuberculosis Programme 1,179 (2024)
Pregnant women tested for HIV in antenatal care Treatment cascade percent 2 2021–2022 UNAIDS AIDSinfo 47.0% (2022)
Pregnant women with HIV who received ARVs for PMTCT Treatment cascade count 33 2010–2025 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory 66 (2025)
TB patients recorded as HIV-positive Treatment cascade count 10 2015–2024 WHO Global Tuberculosis Programme 43 (2024)
TB patients with an HIV test result recorded Treatment cascade count 11 2015–2024 Global Fund Data Service, WHO Global Tuberculosis Programme 3,741 (2024)
AIDS-related deaths Epidemic estimates count 631 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 200 (2025)
Deaths from TB among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 30 (2024)
HIV prevalence among a key population Epidemic estimates percent 5 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
HIV prevalence, ages 15-49 Epidemic estimates percent 50 2000–2024 UNAIDS AIDSinfo, World Bank Open Data 0.1% (2024)
Incident TB cases among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 76 (2024)
New HIV infections Epidemic estimates count 535 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 500 (2025)
People living with HIV Epidemic estimates count 631 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 12,000 (2025)
People newly reported with AIDS, national surveillance Epidemic estimates count 30 2000–2024 HIV/AIDS surveillance in Europe 2025, the joint report of ECDC (the European Centre for Disease Prevention and Control) and the WHO Regional Office for Europe, Tables 1 and 13, WHO Europe Health for All database 120 (2024)
Condom use at last higher-risk sex (household survey) Prevention and outreach percent 1 2006 Demographic and Health Surveys By population group, sex or age only, to 2006
Key-population members reached by prevention programmes Prevention and outreach percent 4 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Key-population people reached by outreach (count over the period) Prevention and outreach count 30 2017–2025 Global Fund Data Service By population group, sex or age only, to 2025
Male condoms distributed in a year Prevention and outreach count 5 2019–2024 UNAIDS AIDSinfo 6,547,855 (2024)
People receiving PrEP Prevention and outreach count 4 2023–2025 Global Fund Data Service, UNAIDS AIDSinfo 1,254 (2025)
People with comprehensive correct knowledge of HIV (household survey) Prevention and outreach percent 22 2006 Demographic and Health Surveys By population group, sex or age only, to 2006
Estimated pregnant women with HIV needing ARVs for PMTCT Population denominators count 16 2010–2025 WHO Global Health Observatory 100 (2025)
Estimated size of a key population Population denominators count 5 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Total population Population denominators count 26 2000–2025 World Bank Open Data 10,246,996 (2025)
Share of HIV-exposed infants who acquire HIV — percent 16 2010–2025 UNICEF HIV/AIDS dataset 17.2% (2025)

Every row shown on the Azerbaijan page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.